Geron (GERN)
(Delayed Data from NSDQ)
$4.71 USD
-0.03 (-0.63%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $4.71 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Brokerage Reports
0 items in cart
Geron Corporation [GERN]
Reports for Purchase
Showing records 61 - 80 ( 247 total )
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Survival Comparison Favors Imetelstat Versus Real World Data; Reiterate Buy and $7 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Steady 1Q21 Progress in Two Imetelstat Phase 3 Trials; Reiterate Buy and $7 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Expecting a Slow Start But a Great Imetelstat IMpactMF; Reiterate Buy and $7 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Clinical Programs Remain on Track in the Worsening COVID-19 Environment; Reiterate Buy and $7 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Imetelstat Following a Steady Positive Trajectory With Phase 3 Move Into MF
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Expecting High Interest in IMerge at ASH 2019 Trials in Progress; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department